Position in GILD
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$2,907,841
-$896,960 QoQ
Shares Held
23,016
-15.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.92%
of 13F equity value
Holder Rank
#723
of 2,266 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MCDONALD PARTNERS LLC holds $28,881,483 across 13 Drug Manufacturers - General names. GILD ranks #4 (10.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
32,121 | $8,157,770 | |
| 2 | AMGN |
Amgen Inc
|
15,929 | $5,768,209 | |
| 3 | ABBV |
AbbVie Inc.
|
20,808 | $5,236,125 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
23,016 | $2,907,841 | |
| 5 | PFE |
Pfizer Inc
|
101,152 | $2,435,740 | |
| 6 | MRK |
Merck & Co., Inc.
|
13,987 | $1,797,329 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
28,302 | $1,630,761 | |
| 8 | LLY |
ELI LILLY & Co
|
678 | $813,213 |
All Filings in GILD
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,907,841 | 23,016 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $3,804,801 | 27,300 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,473,051 | 28,296 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $2,990,895 | 26,945 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,568,525 | 23,167 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,768,643 | 24,709 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,569,363 | 27,816 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $2,716,164 | 32,397 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1,490,003 | 21,717 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $1,813,816 | 24,762 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $2,416,204 | 29,826 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,776,002 | 37,043 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $2,678,567 | 34,755 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $2,862,630 | 34,502 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $3,014,365 | 35,112 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $2,223,677 | 36,046 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $3,012,619 | 48,740 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $2,703,191 | 45,470 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $5,590 | 77 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $3,042,945 | 43,564 | Shares | Sole | 2021-11-24 | |
| 2021-06-30 | $3,004,568 | 43,633 | Shares | Sole | 2021-11-24 | |
| 2021-03-31 | $2,497,820 | 38,648 | Shares | Sole | 2021-11-24 | |
| 2020-12-31 | $1,955,729 | 33,569 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||